In Thursday’s Wall Street session, Eyenovia Inc (NASDAQ:EYEN) shares traded at $2.03, up 45.00% from the previous session.
EYEN stock price is now 67.83% away from the 50-day moving average and -88.95% away from the 200-day moving average. The market capitalization of the company currently stands at $5.86M.
With the price target reduced from $12 to $2, H.C. Wainwright Downgraded its rating from Buy to Neutral for Eyenovia Inc (NASDAQ: EYEN). On March 01, 2021, Northland Capital recently initiated its ‘Outperform’ rating on the stock quoting a target price of $10, while ‘Oppenheimer’ rates the stock as ‘Perform’
In other news, Rowe Michael M, Chief Executive Officer bought 27,071 shares of the company’s stock on Aug 28 ’24. The stock was bought for $14,077 at an average price of $0.52. Upon completion of the transaction, the Chief Executive Officer now directly owns 109,998 shares in the company, valued at $0.22 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 26 ’24, Chief Executive Officer Rowe Michael M bought 50,000 shares of the business’s stock. A total of $28,500 was incurred on buying the stock at an average price of $0.57. This leaves the insider owning 82,927 shares of the company worth $0.17 million. A total of 4.69% of the company’s stock is owned by insiders.
During the past 12 months, Eyenovia Inc has had a low of $0.85 and a high of $124.80. The fifty day moving average price for EYEN is $1.20958 and a two-hundred day moving average price translates $18.3679 for the stock.
The latest earnings results from Eyenovia Inc (NASDAQ: EYEN) was released for 2024-12-31. The net profit margin was -63194.11% and return on equity was -388.03% for EYEN. The company reported revenue of $15000.0 for the quarter, compared to $5000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 200.0 percent.
